42.97
-0.49(-1.13%)
Currency In USD
| Previous Close | 43.46 |
| Open | 44 |
| Day High | 44.99 |
| Day Low | 42.62 |
| 52-Week High | 91.83 |
| 52-Week Low | 26.7 |
| Volume | 249,614 |
| Average Volume | 414,050 |
| Market Cap | 875.26M |
| PE | -4.03 |
| EPS | -10.66 |
| Moving Average 50 Days | 37.81 |
| Moving Average 200 Days | 58.31 |
| Change | -0.49 |
If you invested $1000 in Praxis Precision Medicines, Inc. (PRAX) since IPO date, it would be worth $103.05 as of June 20, 2025 at a share price of $42.97. Whereas If you bought $1000 worth of Praxis Precision Medicines, Inc. (PRAX) shares 3 years ago, it would be worth $1,383.9 as of June 20, 2025 at a share price of $42.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Praxis Precision Medicines to Participate in Upcoming Conferences
GlobeNewswire Inc.
May 20, 2025 12:00 PM GMT
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders character
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
GlobeNewswire Inc.
May 05, 2025 12:00 PM GMT
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders character
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire Inc.
Apr 08, 2025 12:00 PM GMT
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders charact